Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, -interferon, cisplatin (FAP)

Author: Tu S.-M.   Millikan R.E.   Pagliaro L.C.   Daliani D.   Papandreou C.N.   Kim J.   Chen D.-T.   Williams D.L.   Logothetis C.J.  

Publisher: Elsevier

ISSN: 1078-1439

Source: Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.5, 2003-09, pp. : 342-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content